Related Topic: Radioisotopes

Novel method cuts isotope production waste

Novel method cuts isotope production waste

A new method to extract molybdenum-99 from low-enriched uranium targets, developed by researchers at the Technical University of Munich, could significantly reduce the radioactive waste produced during the production of the isotope. Mo-99 is the precursor for medical radioisotope technetium-99m, used in more than 85% of all nuclear medicine diagnostic examinations.

Waste & Recycling 01 April 2022


Belgian regulators OK isotope residue facility

Belgian regulators OK isotope residue facility

Belgium's SCK-CEN nuclear research centre has received all the licences needed for the construction and operation of a facility to support the RECUMO project to manage and recycle radioactive residues from the production of medical radioisotopes.

Waste & Recycling 04 March 2022


South Africa seeks proposals for new research reactor

South Africa seeks proposals for new research reactor

Necsa - the South African Nuclear Energy Corporation - has released a Request for Information for the Multipurpose Reactor to replace the 56-year-old Safari-1 research reactor located at Pelindaba.

New Nuclear 07 February 2022


Financing in place for European SHINE isotope plant

Financing in place for European SHINE isotope plant

SHINE Technologies of the USA has announced its European subsidiary, SHINE Europe, has secured funding to begin designing an advanced medical isotope production facility at Veendam in the Netherlands. 

New Nuclear 02 February 2022


MARIA steps in to maintain Mo-99 supplies

MARIA steps in to maintain Mo-99 supplies

Poland's only operating research reactor - the MARIA reactor at the National Centre for Nuclear Research in Świerk - has been able to rapidly rearrange its work schedule to respond to a shortage of the medical isotope molybdenum-99 due to a fault at the High Flux Reactor in the Netherlands.

Corporate 31 January 2022


Bruce 7 prepares for isotope production

Bruce 7 prepares for isotope production

Bruce unit 7 has become the first nuclear power reactor in the world with installed capability to produce the medical radioisotope lutetium-177. The isotope, which is used in the treatment of cancers such as neuroendocrine tumours and prostate cancer, will be produced from ytterbium targets irradiated in the reactor.

Regulation & Safety 25 January 2022


Bruce Power harvests cobalt-60 to sterilise medical equipment

Bruce Power harvests cobalt-60 to sterilise medical equipment

Enough cobalt-60 to sterilise 10 billion items of medical equipment was recently shipped from unit 7 at Canada's Bruce nuclear power plant. Meanwhile, a new production base for medical radioisotopes is being set up at the Qinshan Phase III nuclear power plant in China.

Corporate 10 January 2022


Framatome and Exelon to explore Co-60 production

Framatome and Exelon to explore Co-60 production

A Memorandum of Understanding between Framatome and Exelon Generation will see the two companies work towards the production of cobalt-60 in pressurised water reactors for medical and industrial uses.

Corporate 05 January 2022


Isotope supplies allow USA to stop HEU exports

Isotope supplies allow USA to stop HEU exports

Worldwide supplies of molybdenum-99 made without using highly enriched uranium are now sufficient for the USA to ban exports of HEU material for foreign medical isotope production.
 

Regulation & Safety 23 December 2021


MoU aims to produce Co-60 in French PWRs

MoU aims to produce Co-60 in French PWRs

Westinghouse Electric Company and EDF have signed a Memorandum of Understanding to produce cobalt-60 in selected pressurised water reactors owned and operated by EDF in France. The agreement is the first step towards production in Europe of the radioisotope for medical uses, the companies said.

Regulation & Safety 02 December 2021